SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

Unichem Laboratories planning to consolidate generics formulations business in US market

23 Sep 2024 Evaluate

Unichem Laboratories is planning for integration and consolidation of the generics formulations business in the US market of M/s Bayshore Pharmaceuticals LLC (wholly owned subsidiary of Company’s holding company, Ipca Laboratories) into Unichem Pharmaceuticals (USA) Inc. (company’s wholly owned subsidiary) so as to consolidate all the Ipca Group’s USA generics formulations business under one entity. The meeting of the Board of Directors of the Company scheduled to be held on September 30, 2024 to consider the same. 

Unichem Laboratories is an international, integrated, specialty pharmaceutical company.


Unichem Lab Share Price

347.50 2.50 (0.72%)
21-Apr-2026 12:12 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1668.75
Dr. Reddys Lab 1220.50
Cipla 1232.55
Zydus Lifesciences 928.60
Lupin 2322.00
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through:

×